Zhang Xiao-Xia, Chen Qing, Zhang Xiao-Jiang, Ding Yao-Dong, Wang Guo-Zhong, Nie Mao-Xiao, Zeng Yong
Department of Cardiology, Beijing Anzhen Hospital Capital Medical University Beijing China.
Health Sci Rep. 2025 Jul 18;8(7):e71072. doi: 10.1002/hsr2.71072. eCollection 2025 Jul.
Treatment of drug-eluting stents (DES) in-stent restenosis (ISR) was challenging. Neoatherosclerosis (NA) occurs earlier and more frequently in DES-ISR. This study aims to analyze the effect of neoatheroma morphology and intervention-associated neoatheroma intima rupture on intervention strategies and clinical outcomes in patients with DES-ISR.
We retrospectively analyzed 56 consecutive patients with symptomatic DES-ISR and optical coherence tomography (OCT) verified in-stent NA who had been treated by repeat stenting or drug-coated balloon (DCB). Patients were divided into two groups according to whether there was severe neoatheroma intima rupture (SNIR) after balloon angioplasty. Characteristics of the neointima were analyzed. Intervention strategies and clinical outcomes were compared between the two groups.
SNIR occurred in 29 patients after balloon angioplasty. Repeat stenting was more frequent in these patients (48.3% vs. 7.4%, = 0.009). The incidence of target lesion revascularization (TLR) was significantly higher in patients with SNIR (37.9% vs. 11.1%, = 0.021), SNIR was an independent risk factors of TLR (HR: 3.997, = 0.034). In patients with SNIR, repeat stenting significantly reduced the rate of TLR than DCB (14.3% vs. 60.0% = 0.014). The lipid pool depth and the maximum lipid arc of the neoatheroma were significantly larger and the percentage of the frame with neoatherosclerosis was significantly higher in patients with SNIR (510.1 ± 162.7 vs. 370.7 ± 129.6 µm, = 0.001; 155.5 ± 41.6 vs. 107.7 ± 44.4 degrees, = 0.000; and 28.2% ± 14.3% vs. 16.0% ± 9.5%, = 0.001, respectively). Multivariate logistic regression demonstrated that HbA1C (OR = 1.868, = 0.044) and time from PCI to ISR (OR = 1.278, = 0.026) were independent predictors of SNIR.
Intervention-associated severe neoatheroma rupture increased the risk of recurrent TLR, repeat stenting was more effective than DCB in such patients. Neoatherosclerosis with a significant lipid pool is closely related to intervention-associated SNIR.
药物洗脱支架(DES)治疗支架内再狭窄(ISR)具有挑战性。新生动脉粥样硬化(NA)在DES-ISR中出现得更早且更频繁。本研究旨在分析新生动脉粥样硬化斑块形态及介入相关新生动脉粥样硬化内膜破裂对DES-ISR患者介入策略和临床结局的影响。
我们回顾性分析了56例有症状的DES-ISR且经光学相干断层扫描(OCT)证实存在支架内NA的患者,这些患者接受了再次支架置入或药物涂层球囊(DCB)治疗。根据球囊血管成形术后是否存在严重新生动脉粥样硬化内膜破裂(SNIR)将患者分为两组。分析新生内膜的特征。比较两组的介入策略和临床结局。
球囊血管成形术后29例患者发生SNIR。这些患者中再次支架置入更为频繁(48.3%对7.4%,P = 0.009)。SNIR患者的靶病变血运重建(TLR)发生率显著更高(37.9%对11.1%,P = 0.021),SNIR是TLR的独立危险因素(HR:3.997,P = 0.034)。在SNIR患者中,再次支架置入比DCB显著降低了TLR发生率(14.3%对60.0%,P = 0.014)。SNIR患者的新生动脉粥样硬化斑块脂质池深度和最大脂质弧显著更大,新生动脉粥样硬化累及节段百分比显著更高(分别为510.1±162.7对370.7±129.6μm,P = 0.001;155.5±41.6对107.7±44.4度,P = 0.000;以及28.2%±14.3%对16.0%±9.5%,P = 0.001)。多因素逻辑回归显示糖化血红蛋白(HbA1C)(OR = 1.868,P = 0.044)和从经皮冠状动脉介入治疗(PCI)到ISR的时间(OR = 1.278,P = 0.026)是SNIR的独立预测因素。
介入相关的严重新生动脉粥样硬化斑块破裂增加了复发性TLR的风险,在此类患者中再次支架置入比DCB更有效。具有显著脂质池的新生动脉粥样硬化与介入相关的SNIR密切相关。